<DOC>
	<DOCNO>NCT01753336</DOCNO>
	<brief_summary>The purpose protocol ass long term safety repeat treatment cycle Dysport 500 U use 2 mL dilution scheme treatment Cervical Dystonia . This extension study study A-TL-52120-169 ( hereafter refer Study 169 ) .</brief_summary>
	<brief_title>Long Term Safety And Effectiveness Of Dysport In Adults With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Subjects enrol Study 169 ongoing adverse event , opinion Investigator relate study treatment preclude receive continue therapy Completed Study 169 , complete study visit include Week 4 event early withdrawal Week 4 â‰¤15 % reduction TWSTRS total score Week 4 compare baseline TWSTRS total score doubleblind study , Investigator 's clinical judgment , would benefit Dysport CD . Diagnosis pure retrocollis pure anterocollis Requirement botulinum toxin injection site ( ) disorder CD unable avoid treatment ( ) duration study Known hypersensitivity botulinum toxin related compound , component study drug formulation Allergy cow 's milk protein</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>